Albumin & Creatinine Tests Market Analysis by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, and Reagents); by Type (Blood & Urine Creatinine, Urine Albumin, and Glycated Albumin); and by End-User (Hospital, Diagnostic & Research Labs) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2035
Buy Now Report ID: 4665 | Published Date: Jan 30, 2023
The global albumin tests market & creatinine tests market is estimated to garner a revenue of ~USD 19 billion by the end of 2035 by growing at a CAGR of ~19% over the forecast period, i.e., 2023 – 2035. Further, the market generated revenue of ~USD 3 billion in the year 2022. The growth of the market can be attributed to the increasing cases of kidney diseases and disorders worldwide. Kidney disease is a serious medical condition that can lead to kidney failure. As per the Centers for Disease Control and Prevention (CDC), more than 1 in 7 adults i.e., 37 million people, suffered from chronic kidney disease in 2021. A variety of urine analysis procedures and products are available to detect such disease, which include multiple kidney treatments as well as regular blood examinations of components such as creatinine, albumin, and the ACR ratio. Urine analysis can provide information about the presence of kidney diseases. It can also help to monitor the progression of kidney diseases and assess the effectiveness of treatment.
Get more information on this report:Download Sample PDF
Additionally, other factors that are anticipated to contribute to the growth of the global albumin tests and creatinine tests market include the increasing awareness of early disease detection among people and the growing preference for home testing for regular monitoring. Additionally, innovations in urine analysis testing is anticipated to contribute to the growth of the market. For instance, Minuteful Kidney is a smartphone-based, home kidney function testing service that is convenient and affordable. The test is easy to use and can be done at home without visiting a doctor. It can be done regularly to help people with diabetes or high blood pressure monitor their kidney health. The result of the patient's test is automatically recorded in the app's electronic medical record, and it is automatically sent to their healthcare practitioner for further action.
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~19% |
|
Base Year Market Size (2022) |
~ USD 3 Billion |
|
Forecast Year Market Size (2035) |
~ USD 19 Billion |
|
Regional Scope |
|
Rising Rates of Hypoalbuminemia and Hypovolemia – Hypoalbuminemia is one of the major factors associated with acute pancreatitis, and it is estimated that hypoalbuminemia affects 30% of patients with acute pancreatitis. In addition, low albumin levels are directly linked to an increased risk of severity and mortality associated with the condition. Thus, the level of serum albumin in the blood must be continually monitored. A continuous and frequent albumin test is required to monitor serum albumin levels. Hence, these factors are anticipated to lead to positive growth in the market.
Increasing Prevalence of Chronic Disease Conditions – The prevalence of chronic diseases leads to various kidney disorders, whose severity is assessed by two laboratory tests including creatinine levels and albumin levels in the urine. According to the World Health Organization, approximately 41 million people die every year from chronic diseases across the world, which accounts for 74% of all global deaths.
Rising Expenditure on Life Science and Medical Research – The United States Government spent more than USD 3 billion in 2019 on health research and development, with the global export value of medical technology products from the UK being nearly USD 5 billion in 2020. Rising expenditure on life science and medical research is creating opportunities for companies that provide integrated systems for albumin and creatinine tests. Increased funding for medical research is expected to drive the market’s growth.
Fast Growth in the Field of Diagnostics and Increasing Demand for Easy-to-use Kits – In India, the National Accreditation Board of Laboratories increased from 500 in 2015 to 1200 in 2020, which accounts for approximately 1% of total labs in India, as per the estimations. The number of accredited laboratories in various regions has increased rapidly in recent years, owing to the increasing demand for easy-to-use diagnostic kits.
Growing Geriatric Population and Increasing Practice of Sedentary Lifestyle – As per the World Health Organization, the worldwide old age population is estimated to double and reach 2.1 billion by 2050, from a base of 1 billion in 2020. The geriatric population is more susceptible to chronic diseases such as kidney disease. The sedentary lifestyle of this population group leads to further complications and health risks.
Challenges
The global albumin tests market & creatinine tests market is segmented and analyzed for demand and supply by type into blood & urine creatinine, urine albumin, and glycated albumin. Out of these, the urine albumin segment is estimated to gain the largest market share over the projected time frame. Albuminuria (urine albumin) is a sign of kidney disease and is characterized by excessive albumin levels in the urine. It has been observed that the proportion of patients who have urine albumin laboratory results is increasing over time in every age group, along with the resulting increase in consumer demand for convenient and rapid urine tests, which is expected to drive segment growth throughout the forecast period. As a result of a survey conducted in the United States between 2005 and 2019, it was found that the percentage of people with urine albumin results increased from 6%–16% among 40–49-year-olds; 11%–22% among 50–59-year-olds, 12%–27% among 60-69-year-olds and 10%–25% for those older than 70.
The global albumin tests market & creatinine tests market is also segmented and analyzed for demand and supply by-product into analyzers, cartridges (POC, tabletop), dipsticks & kits, and reagents. Amongst these segments, the dipsticks & kits segment is expected to garner a significant share by the end of 2035. The albumin & creatinine tests are used to detect kidney damage, and the kits for these tests are becoming more popular as they are less expensive and easier to use than traditional analyzers and cartridges. Moreover, a urine dipstick test is a quick and easy way to test for the presence of various substances in the urine, such as protein, blood, and sugar. The results are usually available between 60 and 120 seconds after an appointment with the doctor. Therefore, such factors are expected to fuel the growth of the segment in the future.
Our in-depth analysis of the global albumin tests market & creatinine tests market includes the following segments:
|
By Product |
|
|
By Type |
|
|
By End User |
|
The North American albumin tests market & creatinine tests market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. Growth in the regional market can be attributed primarily to the increasing prevalence of chronic diseases and the rise in healthcare spending by the general population. Furthermore, chronic diseases such as type 1 or type 2 diabetes, high blood pressure, and obesity can lead to kidney diseases. With the growing incidence of these diseases, rapid urine testing has become an increasingly crucial method of diagnosing kidney disorders. The prevalence of obesity, a chronic disease condition, in the U.S. from 2017 to 2020 rose from 30.5% to 41.9% and in the same period, the prevalence of severe obesity rose from 4.7% to 9.2%, as per the Centers for Disease Control and Prevention. Additionally, according to the same source, more than 37 million Americans suffer from diabetes, with approximately 90-95% having diabetes type 2 most commonly occurs in adults over 45.
Sysmex Corporation introduced a new product named as UF-1500 Fully Automated Urine Particle Analyzer (UF-1500). The UF-1500 is a new product that automates the process of testing urine sediments. This will allow for faster and more accurate results.
Siemens Healthcare GmbH declared the global OEM partnership to enhance patient monitoring with chronic kidney diseases. Using Healthy. Io's smartphone-based urinalysis system, the company's urinalysis reagents allow patients to conduct home testing
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Rising rates of hypoalbuminemia and hypovolemia and the rising geriatric population are the major factors driving the market growth.
Ans: The market is anticipated to attain a CAGR of ~19% over the forecast period, i.e., 2023 – 2035.
Ans: The increased price of the automated analyzer and the lack of accuracy of the test are estimated to be the growth hindering factors for the market expansion.
Ans: The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Ans: The major players in the market are RayBiotech Life, Inc., Danaher Corporation, FUJIFILM Wako Pure Chemical Corporation, Nova Biomedical, Ortho Clinical Diagnostics, PromoCell GmbH, Siemens Healthineers, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific Holdings, Inc.
Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by product, type, end-user, and by region.
Ans: The urine albumin segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
